Fosaprepitant Injection and Insulin degludec and liraglutide Subcutaneous
Determining the interaction of Fosaprepitant Injection and Insulin degludec and liraglutide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: fosaprepitant
Brand name: Emend for Injection
Synonyms: Fosaprepitant
Generic Name: insulin degludec / liraglutide
Brand name: Xultophy
Synonyms: Insulin degludec and liraglutide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Fosaprepitant Injection-Insulin degludec Subcutaneous
- Fosaprepitant Injection-Insulin detemir
- Fosaprepitant Injection-Insulin Detemir (Cartridges and Prefilled Syringes)
- Fosaprepitant Injection-Insulin Detemir (Vials)
- Fosaprepitant Injection-Insulin detemir Subcutaneous
- Fosaprepitant Injection-Insulin glargine
- Insulin degludec and liraglutide Subcutaneous-Fosaprepitant Intravenous
- Insulin degludec and liraglutide Subcutaneous-Foscarnet
- Insulin degludec and liraglutide Subcutaneous-Foscarnet Intravenous
- Insulin degludec and liraglutide Subcutaneous-Foscarnet Sodium
- Insulin degludec and liraglutide Subcutaneous-Foscavir
- Insulin degludec and liraglutide Subcutaneous-Fosfomycin